<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002006'>Tumorigenesis</z:mp> and the efficacy of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapeutics are both defined by the balance between autophagy and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>High-mobility group box 1 (HMGB1) is a DNA chaperone and extracellular damage-associated molecular pattern molecule (<z:chebi fb="14" ids="17713">DAMP</z:chebi>) with pro-autophagic activity </plain></SENT>
<SENT sid="2" pm="."><plain>TP53/p53 plays a transcription-dependent and -independent role in the regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, autophagy, metabolism, cell cycle progression, and many other processes </plain></SENT>
<SENT sid="3" pm="."><plain>Both HMGB1 and TP53 are tightly linked with the development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, associated with many of the hallmarks defining the altered biology of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We have demonstrated that TP53-HMGB1 complexes regulate the balance between <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and autophagy through regulation of the cytosolic localization of the reciprocal binding partner, whereby increased cytosolic HMGB1 enhances autophagy and increased cytosolic TP53 enhances <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="5" pm="."><plain>We found that HMGB1-mediated autophagy promotes cell survival in TP53-dependent processes, and that TP53 inhibits autophagy through negative regulation of HMGB1-BECN1 complexes </plain></SENT>
<SENT sid="6" pm="."><plain>Nuclear localization of TP53 and HMGB1 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from patients with <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp> had a positive trend with survival time from diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, HMGB1 and TP53 are critical in the cross-regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and autophagy and central to <z:hpo ids='HP_0003003'>colon cancer</z:hpo> biology </plain></SENT>
</text></document>